Sunday, September 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Mizuho Analyst Upgrades Fidelity National Information Services FIS with 76 Price Target

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
Healthcare cloud based
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

On February 28, 2024, Mizuho analyst Dan Dolev expressed optimism in Fidelity National Information Services (NYSE:FIS) by maintaining a Buy rating and raising the price target to $76 from $73. This adjustment underscores a bullish perspective on the company’s trajectory and market expansion. The heightened price target signifies a strong belief in FIS’s future opportunities and financial stability, according to Mizuho analysts.

FIS Stock Fluctuates on February 28, 2024: Investors Eye Positive Momentum

On February 28, 2024, FIS stock experienced some fluctuations in its performance. The stock closed at $66.98, which was a decrease of $0.35 or 0.52% from the previous market close. Despite this drop, FIS was still trading near the top of its 52-week range and above its 200-day simple moving average, indicating some positive momentum for the stock.

After the market closed, FIS saw a slight uptick in its price, with the stock rising $0.17 in after-hours trading. This could be a sign of investor confidence in the company’s future prospects.

Overall, FIS stock showed mixed performance on February 28, 2024. While there was a slight drop in price during regular trading hours, the stock managed to recover some of its losses in after-hours trading. Investors will be keeping a close eye on FIS in the coming days to see if this positive momentum continues.

Fidelity National Information Services (FIS) Stock Performance Analysis: Mixed Results on February 28, 2024

On February 28, 2024, Fidelity National Information Services (FIS) stock performance showed some interesting trends based on the latest financial data. According to CNN Money, the company reported a total revenue of $9.82 billion for the past year, which decreased by 32.4% compared to the previous year. However, the total revenue remained flat at $2.51 billion for the last quarter.

In terms of net income, FIS reported a net loss of $6.65 billion for the past year, but the net income improved significantly by 60.2% to $63 million for the last quarter. Despite this improvement, there was a decrease of 75.77% in net income compared to the previous quarter.

Earnings per share (EPS) for FIS also showed some interesting movements. The EPS was reported at -$11.26 for the past year, which represented an increase of 59.33% compared to the previous year. However, the EPS remained flat at $0.42 for the last quarter.

Overall, the financial performance of FIS on February 28, 2024, indicated mixed results. While there were improvements in net income and EPS compared to the previous year, there were decreases in total revenue and net income compared to the previous quarter. Investors and analysts may need to closely monitor these trends to assess the future prospects of FIS stock.

Tags: FIS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Automating Financial Advisory Services: The Rise of End-to-End Solutions for RIAs

Scilex Holding Company Partners with National Pharmacy Chains to Distribute GLOPERBA Expanding Access to Effective Gout Flare Prophylaxis

Luxury vacation

Polestar Automotive Quarterly Earnings Preview

Finance_Assets (3)

Investors Guide What to Expect from Cronos Groups Latest Earnings Report

Recommended

Karyopharm Therapeutics Stock

Karyopharm Therapeutics: Surging Shares Mask Growing Technical Concerns

4 weeks ago
Healthcare-sector

Analyzing Short Interest in Molina Healthcare Inc MOH

2 years ago
Opendoor Stock

Leadership Shakeup Sends Opendoor Shares on a Wild Ride

1 week ago
Does_Starbucks_Accept_EBT

Does Starbucks Accept EBT? Exploring the Intersection of Convenience and Government Regulations

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla Tilray TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Groupon Shares Surge as Analysts Issue Bullish Upgrades

OMV Faces Dual Challenges: Espionage Scandal and Major Restructuring

EssilorLuxottica Shares Gain Momentum on AI Eyewear and Analyst Upgrade

LexinFintech Shares Garner Bullish Outlook Despite Recent Pullback

Viking Therapeutics Stock Stages Impressive Recovery

Fiserv Faces Investor Backlash Amid Clover Platform Concerns

Trending

Waterstone Stock
Analysis

Waterstone Financial Shares Show Resilience Amid Sector Volatility

by Andreas Sommer
September 21, 2025
0

Shares of regional US banking institution Waterstone Financial are demonstrating signs of stabilization following a period of...

Union Pacific Stock

Political Backing Fuels Speculation Over Major Railroad Merger

September 21, 2025
Century Therapeutics Stock

Is Century Therapeutics Stock a High-Stakes Turnaround Play?

September 21, 2025
Groupon Stock

Groupon Shares Surge as Analysts Issue Bullish Upgrades

September 21, 2025
OMV PK Stock

OMV Faces Dual Challenges: Espionage Scandal and Major Restructuring

September 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Waterstone Financial Shares Show Resilience Amid Sector Volatility
  • Political Backing Fuels Speculation Over Major Railroad Merger
  • Is Century Therapeutics Stock a High-Stakes Turnaround Play?

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com